Private Equity Firm to Purchase Johnson & Johnson Ortho-Clinical Business for $4.15B

Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson’s ortho-clinical testing business for $4.15 billion, according to a Mass Device report.

Advertisement

The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.

More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.